Company news

Immuron Limited news in 2018

Immuron Limited's news releases, calls and decks from 2018, newest first.

View company

IMC Appoints Experienced US Based Biotech Executive as CEO

November 18, 2018

NASH clinical trial presentation & continued revenue growth

November 9, 2018

US DoD Report Travelan Protects Against Shigella in Primates

September 4, 2018

Immuron Reports Record Revenue

July 25, 2018

US Department of Defense Research Collaboration Moves Ahead

July 15, 2018

European Patent Gramted for Nash Treatment

July 11, 2018

Immuron Announces Board Appointment

June 26, 2018

IMC Preclinical Study Reports Reduction in Colitis Symptoms

May 8, 2018

Travelan Sales Continue to Soar in Third Quarter of FY2018

April 23, 2018

Immuron Announces A$5.1M Private Placement to U.S. Fund

March 13, 2018

Immuron Reports Positive Results in NASH Clinical Trial

March 7, 2018

Correction to False and Misleading News Release

March 6, 2018

Appendix 4D - Half Year Financial Report - 31 Dec 2017

February 27, 2018

Travelan Revenue Grows Significantly in US and Australia

February 16, 2018

US Defence Depart Report-Travelan Targets Priority Pathogens

January 29, 2018

Immuron to Receive $2.16M R&D Tax Concession Cash Refund

January 22, 2018

Decks in 2018